v3.26.1
SHARE-BASED COMPENSATION PLANS (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Nonvested Restricted Shares Activity
The following table presents a summary of nonvested restricted shares activity for the six months ended June 30, 2026:
SharesWeighted Average Grant Date Fair Value
Nonvested shares, beginning of year253,755 $30.47 
Granted196,200 36.63 
Forfeited(1,287)36.40 
Vested(151,906)30.66 
Nonvested shares, at period end296,762 $34.42 
Summary of Restricted Shares Compensation Expense
The following table presents restricted share compensation expense, with tax benefit information, and fair value of shares vested, for the three and six months ended June 30, 2026 and 2025:
Three months ended June 30,Six months ended June 30,
2026202520262025
Restricted share award expense$1,776 $1,287 $3,309 $2,641 
Restricted share award tax benefit373 270 695 555 
Fair value of shares vested3,013 30 5,666 1,506 
Summary of Stock Options Activity
The following table presents the summary of stock option activity for the six months ended June 30, 2026. The weighted average of remaining contractual term of shares exercisable is 1.5 years.
SharesWeighted Average
Exercise Price
Outstanding at January 1, 2026
13,202 $25.29 
Exercised(2,160)21.23 
Outstanding at end of period11,042 26.09 
Fully vested and expected to vest11,042 26.09 
Exercisable, at June 30, 2026
11,042 $26.09 
The following table presents information about stock options exercised for the six months ended June 30, 2026 and 2025:
June 30, 2026June 30, 2025
Total intrinsic value of options exercised$33 $134 
Cash received from options exercised46 508 
Tax benefit realized from stock options exercised7 30 
Summary of Employee Stock Purchase Plan
The following table presents information for the employee stock purchase plan for the three and six months ended June 30, 2026 and 2025:
Three months ended June 30,Six months ended June 30,
2026202520262025
Shares purchased— — 2,278 2,080 
Weighted average price of shares purchased$— $— $32.97 $31.83 
Compensation expense recognized$— $— $7 $3